{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00733",
      "entity_text" : "CD8+",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O95760",
      "entity_text" : "IL-33",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Similar outcomes have been shown in which IL-33, as a potent molecular adjuvant, can augment protective antiviral CD8+ T cell responses induced by a vaccine and boost DNA vaccine induced protective anti-tumor T cell responses [XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-03T11:55:42Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T11:51:35Z",
  "trigger" : "augment",
  "evidence" : [ "IL-33, as a potent molecular adjuvant, can augment protective antiviral CD8+" ],
  "pmc_id" : "7174000",
  "score" : 0
}